This topic contains a solution. Click here to go to the answer

Author Question: The patient receives dantrolene (Dantrium). A consulting physician orders hydroxyzine (Vistaril) for ... (Read 52 times)

mpobi80

  • Hero Member
  • *****
  • Posts: 519
The patient receives dantrolene (Dantrium). A consulting physician orders hydroxyzine (Vistaril) for the patient and he begins taking it. What will the best assessment by the nurse reveal?
 
  1. Confusion
  2. Hypertension
  3. Respiratory depression
  4. Delirium

Question 2

The patient is started on a medication to treat a neuromuscular disorder. What does the nurse teach as the primary therapeutic goal of the medication?
 
  1. To stop the patient's muscle spasms
  2. To improve the patient's appearance
  3. To promote exercise in the patient
  4. To allow the patient increased independence



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blakcmamba

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

Correct Answer: 3
Rationale: Dantrolene (Dantrium) and hydroxyzine (Vistaril) are both central nervous system (CNS) depressants, and the patient needs to be assessed for respiratory depression. Hypertension would not result from the use of these two medications. Confusion would not result from the use of these two medications. Delirium would not result from the use of these two medications.

Answer to Question 2

Correct Answer: 4
Rationale: The therapeutic goals of pharmacotherapy include minimizing pain and discomfort, increasing range of motion, and improving the patient's ability to function independently. Stopping muscle spasms can be achieved, but this is not the primary goal. Promoting exercise is not a goal. Improving the patient's appearance is not a goal.




mpobi80

  • Member
  • Posts: 519
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library